Cadent Therapeutics is a neuroscience company that develops a pipeline of medicines. It offers novel allosteric modulators of ion channels that aim to restore cognitive and motor functions. The Company also develops therapies to treat spinocerebellar ataxia, essential tremor and schizophrenia.
|Employees (est.) (Jan 2020)||26||(+4%)|
Cadent Therapeutics total Funding
Cadent Therapeutics latest funding size
Time since last funding
|a year ago|
Cadent Therapeutics investors
|Atlas Venture, Qiming Venture Partners, Cowen Healthcare Investments, Novartis Institutes for Biomedical Research|
Cadent Therapeutics has 470 Twitter Followers. The number of followers has increased 5% month over month and increased 10.3% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Cadent Therapeutics founded?
Cadent Therapeutics was founded in 2017.
How many employees does Cadent Therapeutics have?
Cadent Therapeutics has 26 employees.
Who are Cadent Therapeutics competitors?
Competitors of Cadent Therapeutics include Xoc Pharmaceuticals, ProPhase Labs and TrovaGene.
Where is Cadent Therapeutics headquarters?
Cadent Therapeutics headquarters is located at 60 Hamilton Street, Cambridge.
Where are Cadent Therapeutics offices?
Cadent Therapeutics has an office in Cambridge.
How many offices does Cadent Therapeutics have?
Cadent Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies